{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:56:12Z","timestamp":1792828572720,"version":"4.5.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/19810-2"],"award-info":[{"award-number":["2013\/19810-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/07504-2"],"award-info":[{"award-number":["2016\/07504-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00582","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T04:18:37Z","timestamp":1566965917000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension as First Manifestations of Multiple Endocrine Neoplasia Type 1"],"prefix":"10.3389","volume":"10","author":[{"given":"Naiara C. B.","family":"Dantas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E. L.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel R. A.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Delmar M.","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R. P.","family":"Quidute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1530\/EJE-08-0153","article-title":"Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile","volume":"159","author":"Louren\u00e7o","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.12688\/f1000research.7230.1","article-title":"Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old","volume":"6","author":"Falchetti","year":"2017","journal-title":"F1000Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verg\u00e8s","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 Study Group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00006123-199608000-00008","article-title":"Results of treatment of pituitary disease in multiple endocrine neoplasia, type I","volume":"39","author":"O'Brien","year":"1996","journal-title":"Neurosurgery"},{"key":"B8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/EJE-14-0013","article-title":"Therapy of endocrine disease: the challenges in managing giant prolactinomas","volume":"170","author":"Maiter","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11102-016-0723-4","article-title":"Giant prolactinomas larger than 60 mm in size : a cohort of massive and aggressive prolactin-secreting pituitary adenomas","volume":"19","author":"Shimon","year":"2016","journal-title":"Pituitary"},{"key":"B10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1055\/a-0752-0741","article-title":"Giant prolactinoma in men : clinical features and therapeutic outcomes","volume":"50","author":"Iglesias","year":"2018","journal-title":"Horm Metab Res"},{"key":"B11","first-page":"129","article-title":"Treatment of extensively invasive (giant) prolactinomas with bromocriptine","volume":"105","author":"Grebe","year":"1992","journal-title":"N Z Med J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3171\/jns.2002.97.2.0299","article-title":"Giant prolactinomas: clinical management and long-term follow up","volume":"97","author":"Shrivastava","year":"2002","journal-title":"J Neurosurg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2875074","article-title":"Case report giant prolactinoma of young onset : a clue to diagnosis of MEN-1 syndrome","volume":"2018","author":"Subasinghe","year":"2018"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13633-015-0011-5","article-title":"Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1","volume":"2015","author":"Gan","year":"2015","journal-title":"Int J Pediatr Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'\u00e9tude des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12020-017-1322-5","article-title":"MEN1 in children and adolescents: data from patients of a regional referral center for hereditary endocrine tumors","volume":"59","author":"Vannucci","year":"2018"},{"key":"B17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1507\/endocrj.49.635","article-title":"Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type 1","volume":"49","author":"Oiwa","year":"2002","journal-title":"Endocr J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1055\/s-0029-1216358","article-title":"An intronic mutation is associated with prolactinoma in a young boy, decreased penetrance in his large family, and variable effects on MEN1 mRNA and protein","volume":"41","author":"Drori-Herishanu","year":"2009","journal-title":"Horm Metab Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1210\/jc.2014-3670","article-title":"Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients","volume":"100","author":"Salenave","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1399-0004.2010.01406.x","article-title":"The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes","volume":"78","author":"Stratakis","year":"2010","journal-title":"Clin Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1210\/jc.83.8.2777","article-title":"Prolactinomas in children and adolescents. clinical presentation and long-term follow-up","volume":"83","author":"Colao","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1046\/j.1365-2265.2003.01748.x","article-title":"Clinical presentation and outcome of pituitary adenomas in teenagers","volume":"58","author":"Cannav\u00f2","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11102-008-0149-8","article-title":"Clinical profile and long term follow up of children and adolescents with prolactinomas","volume":"12","author":"Acharya","year":"2009","journal-title":"Pituitary"},{"key":"B25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00381-015-2679-5","article-title":"Prolactinomas in children under 14. Clinical presentation and long-term follow-up","volume":"31","author":"Liu","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"B26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00431-017-3042-5","article-title":"Pediatric prolactinoma : initial presentation, treatment, and long-term prognosis","volume":"177","author":"Hoffmann","year":"2018","journal-title":"Eur J Pediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1530\/EJE-10-0519","article-title":"Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes","volume":"163","author":"Steele","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1089\/thy.2016.0148","article-title":"Assessment of depression, anxiety, quality of life, and coping in long-standing multiple endocrine neoplasia type 2 patients","volume":"27","author":"Rodrigues","year":"2017","journal-title":"Thyroid"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.2217\/fon.12.149","article-title":"Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: successful resolution of hydrocephalus by use of medical therapy","volume":"8","author":"Cackett","year":"2012","journal-title":"Futur Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4103\/2230-8210.152771","article-title":"Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: an observational study in Algerian population","volume":"19","author":"Chentli","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00004728-198402000-00027","article-title":"Rapid size reduction of giant prolactinoma following medical treatment","volume":"8","author":"Perani","year":"1984","journal-title":"J Comput Assist Tomogr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0025-6196(11)65126-4","article-title":"Prolactinoma manifesting with symptomatic hydrocephalus","volume":"74","author":"Zikel","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"B33","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/ageing\/30.5.426","article-title":"Fluctuating confusional state due to massive macro-prolactinoma resulting in obstructive hydrocephalus","volume":"30","author":"Sarkar","year":"2001","journal-title":"Age Ageing"},{"key":"B34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1023\/A:1025334001748","article-title":"Falsely low serum prolactin in two cases of invasive macroprolactinoma","volume":"5","author":"Sch\u00f6fl","year":"2002","journal-title":"Pituitary"},{"key":"B35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/ageing\/afh108","article-title":"Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy","volume":"33","author":"Iglesias","year":"2004","journal-title":"Age Ageing"},{"key":"B36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11060-005-2319-0","article-title":"Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment","volume":"76","author":"Scarone","year":"2006","journal-title":"J Neurooncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4183\/aeb.2011.95","article-title":"Giant prolactinoma: an unusual case of obstructive hydrocephalus","volume":"7","author":"Tasma","year":"2011","journal-title":"Acta Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4137\/CCRep.S9675","article-title":"Obstructive hydrocephalus, fifth nerve and hypothalamus involvement: Acute presentation of a giant prolactinoma","volume":"5","author":"Alkatari","year":"2012","journal-title":"Clin Med Insights Case Rep"},{"key":"B39","first-page":"149","article-title":"Haemorrhagic necrosis of a pituitary adenoma in a case of multiple endocrine neoplasia","volume":"138","author":"Labauge","year":"1982","journal-title":"Rev Neurol (Paris)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/0002-9343(87)90668-1","article-title":"Giant invasive prolactinomas","volume":"83","author":"Murphy","year":"1987","journal-title":"Am J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/EJE-13-0503","article-title":"Giant prolactinomas in women","volume":"170","author":"Delgrange","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1507\/endocrj.45.529","article-title":"Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment","volume":"45","author":"Saeki","year":"1998","journal-title":"Endocr J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4158\/EP09221.OR","article-title":"Giant prolactinoma and effectiveness of medical management","volume":"16","author":"Acharya","year":"2010","journal-title":"Endocr Pract"},{"key":"B45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11102-007-0009-y","article-title":"Clinical presentation and response to therapy in patients with massive prolactin hypersecretion","volume":"10","author":"Mascarell","year":"2007","journal-title":"Pituitary"},{"key":"B46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11102-005-5087-0","article-title":"Combined treatment of invasive giant prolactinomas","volume":"8","author":"Yu","year":"2005","journal-title":"Pituitary"},{"key":"B47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3171\/jns.2006.104.1.54","article-title":"Bromocriptine treatment of invasive giantprolactinomas involving the cavernous sinus: results of a long-term follow up","volume":"104","author":"Wu","year":"2006","journal-title":"J Neurosurg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/cen.12242","article-title":"Giant prolactinomas: the therapeutic approach","volume":"79","author":"Moraes","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11102-005-5111-4","article-title":"Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men","volume":"8","author":"Chattopadhyay","year":"2005","journal-title":"Pituitary"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1210\/jc.83.8.2621","article-title":"Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism","volume":"83","author":"Teh","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2007.02895.x","article-title":"Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1","volume":"67","author":"Toledo","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1590\/S1807-59322007000400014","article-title":"The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1","volume":"62","author":"Louren\u00e7o","year":"2007","journal-title":"Clinics (Sao Paulo)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1530\/EJE-18-0430","article-title":"Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencing","volume":"179","author":"Carvalho","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00582\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T02:35:31Z","timestamp":1569983731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00582\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":54,"alternative-id":["10.3389\/fendo.2019.00582"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00582","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"article-number":"582"}}